Pediatric Oncology News

Healio will present its fourth annual Disruptive Innovators Awards for oncology/hematology this spring.

Obesity at cancer diagnosis appeared linked to significantly poorer survival among children and adolescents, according to results of a retrospective study.

SAN DIEGO — A bicistronic chimeric antigen receptor T-cell therapy induced durable response for most children with relapsed or refractory B-lineage acute lymphoblastic leukemia, findings presented at ASH Annual Meeting and Exposition showed.

SAN DIEGO — The addition of blinatumomab to chemotherapy extended DFS for children with newly diagnosed B-cell acute lymphoblastic leukemia, according to results of a randomized phase 3 trial presented at ASH Annual Meeting and Exposition.

Children with cancer more often died at home less often than adults, according to study results.

Researchers found various trends in melanoma incidence among young patients, one of which is that rates are steadily decreasing, according to a study.

Chimeric antigen receptor T-cell therapy can reduce tumor burden and improve neurologic function for patients with certain brain and spinal cord cancers, a first-in-human clinical trial showed.

One-third of childhood cancer survivors reported high levels of fear of cancer recurrence even decades after treatment, according to results of a cross-sectional analysis.

The FDA has expanded the approval of an oral liquid methotrexate solution to include children and adolescents with polyarticular juvenile idiopathic arthritis and acute lymphoblastic leukemia, according to a press release.